EIF2AK3 and melanoma: On the other hand, activation of the PERK-eIF2α pathway through pharmacological ER stress induced B7H6 expression (a ligand for the NK cell receptor NKp30) and rendered melanoma cells more susceptible to killing by chimeric antigen receptor (CAR) T cells that target B7H6 [164].